ICAZ LP 5 mg, extended-release capsule 30 capsules, CIP 3400933333928
Active ingredients: Isradipine
Commercialized according to BDPMDispensing in France: Prescription only
Extended-release capsule30 capsules, CIP 3400933333928orale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ICAZ LP 5 mg, gélule à libération prolongée
- Pharmaceutical form
- gélule à libération prolongée
- Route of administration
- orale
- Presentation description
- film(s) thermosoudé(s) polyamide aluminium PVC-Aluminium de 30 gélule(s)
- Marketing authorisation holder
- FARMACEUTICO SIT
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 17 Nov 2022
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65664910CIP73333392CIP133400933333928Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ISRADIPINEgélule | 5 mg · une gélule | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.